Plantamajoside from Plantago asiatica modulates human umbilical vein endothelial cell dysfunction by glyceraldehyde-induced AGEs via MAPK/NF-ΚB

Won rak Son, Mi Hyun Nam, Chung Oui Hong, Yoonsook Kim, Kwang Won Lee

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Plantago asiatica has been traditionally used for traditional medicine around East Asia. Plantamajoside (PM), which is isolated from this plant, is known for biological properties including anti-inflammation and antioxidant activity. To demonstrate the biological activity of PM against endothelial dysfunction induced by advanced glycation end-products (AGEs), a cellular inflammatory mechanism system was evaluated in human umbilical vein endothelial cells (HUVECs). Methods: We obtained PM through previous research in our laboratory. We formed the AGEs from bovine serum albumin with glyceraldehyde in the dark for seven days. To confirm the modulation of the inflammatory mechanism in endothelial dysfunction, we quantified the various pro-inflammatory cytokines and endothelial dysfunction-related proteins in the HUVECs with Western blotting and with real-time and quantitative real-time polymerase chain reactions. Results: Co-treatment with PM and AGEs significantly suppressed inflammatory cytokines and adhesion molecule expression. Moreover, the PM treatment for down-regulated inflammatory signals and blocked monocyte adhesion on the HUVECs. Conclusions: Theses results demonstrated that PM, as a potential natural compound, protects AGE-induced endothelial cells against inflammatory cellular dysfunction.

Original languageEnglish
Article number66
JournalBMC Complementary and Alternative Medicine
Volume17
Issue number1
DOIs
Publication statusPublished - 2017 Jan 21

Fingerprint

Plantago
Glyceraldehyde
Advanced Glycosylation End Products
Human Umbilical Vein Endothelial Cells
East Asian Traditional Medicine
Cytokines
plantamajoside
Real-Time Polymerase Chain Reaction
Monocytes
Endothelial Cells
Antioxidants
Western Blotting
Inflammation
Therapeutics
Research

Keywords

  • Adhesion molecule
  • Advanced glycation end-products
  • Endothelial dysfunction
  • Monocyte adhesion
  • Plantamajoside

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Plantamajoside from Plantago asiatica modulates human umbilical vein endothelial cell dysfunction by glyceraldehyde-induced AGEs via MAPK/NF-ΚB. / Son, Won rak; Nam, Mi Hyun; Hong, Chung Oui; Kim, Yoonsook; Lee, Kwang Won.

In: BMC Complementary and Alternative Medicine, Vol. 17, No. 1, 66, 21.01.2017.

Research output: Contribution to journalArticle

@article{8d03e9fa76144ed5acb662a3de5a9913,
title = "Plantamajoside from Plantago asiatica modulates human umbilical vein endothelial cell dysfunction by glyceraldehyde-induced AGEs via MAPK/NF-ΚB",
abstract = "Background: Plantago asiatica has been traditionally used for traditional medicine around East Asia. Plantamajoside (PM), which is isolated from this plant, is known for biological properties including anti-inflammation and antioxidant activity. To demonstrate the biological activity of PM against endothelial dysfunction induced by advanced glycation end-products (AGEs), a cellular inflammatory mechanism system was evaluated in human umbilical vein endothelial cells (HUVECs). Methods: We obtained PM through previous research in our laboratory. We formed the AGEs from bovine serum albumin with glyceraldehyde in the dark for seven days. To confirm the modulation of the inflammatory mechanism in endothelial dysfunction, we quantified the various pro-inflammatory cytokines and endothelial dysfunction-related proteins in the HUVECs with Western blotting and with real-time and quantitative real-time polymerase chain reactions. Results: Co-treatment with PM and AGEs significantly suppressed inflammatory cytokines and adhesion molecule expression. Moreover, the PM treatment for down-regulated inflammatory signals and blocked monocyte adhesion on the HUVECs. Conclusions: Theses results demonstrated that PM, as a potential natural compound, protects AGE-induced endothelial cells against inflammatory cellular dysfunction.",
keywords = "Adhesion molecule, Advanced glycation end-products, Endothelial dysfunction, Monocyte adhesion, Plantamajoside",
author = "Son, {Won rak} and Nam, {Mi Hyun} and Hong, {Chung Oui} and Yoonsook Kim and Lee, {Kwang Won}",
year = "2017",
month = "1",
day = "21",
doi = "10.1186/s12906-017-1570-1",
language = "English",
volume = "17",
journal = "BMC Complementary and Alternative Medicine",
issn = "1472-6882",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Plantamajoside from Plantago asiatica modulates human umbilical vein endothelial cell dysfunction by glyceraldehyde-induced AGEs via MAPK/NF-ΚB

AU - Son, Won rak

AU - Nam, Mi Hyun

AU - Hong, Chung Oui

AU - Kim, Yoonsook

AU - Lee, Kwang Won

PY - 2017/1/21

Y1 - 2017/1/21

N2 - Background: Plantago asiatica has been traditionally used for traditional medicine around East Asia. Plantamajoside (PM), which is isolated from this plant, is known for biological properties including anti-inflammation and antioxidant activity. To demonstrate the biological activity of PM against endothelial dysfunction induced by advanced glycation end-products (AGEs), a cellular inflammatory mechanism system was evaluated in human umbilical vein endothelial cells (HUVECs). Methods: We obtained PM through previous research in our laboratory. We formed the AGEs from bovine serum albumin with glyceraldehyde in the dark for seven days. To confirm the modulation of the inflammatory mechanism in endothelial dysfunction, we quantified the various pro-inflammatory cytokines and endothelial dysfunction-related proteins in the HUVECs with Western blotting and with real-time and quantitative real-time polymerase chain reactions. Results: Co-treatment with PM and AGEs significantly suppressed inflammatory cytokines and adhesion molecule expression. Moreover, the PM treatment for down-regulated inflammatory signals and blocked monocyte adhesion on the HUVECs. Conclusions: Theses results demonstrated that PM, as a potential natural compound, protects AGE-induced endothelial cells against inflammatory cellular dysfunction.

AB - Background: Plantago asiatica has been traditionally used for traditional medicine around East Asia. Plantamajoside (PM), which is isolated from this plant, is known for biological properties including anti-inflammation and antioxidant activity. To demonstrate the biological activity of PM against endothelial dysfunction induced by advanced glycation end-products (AGEs), a cellular inflammatory mechanism system was evaluated in human umbilical vein endothelial cells (HUVECs). Methods: We obtained PM through previous research in our laboratory. We formed the AGEs from bovine serum albumin with glyceraldehyde in the dark for seven days. To confirm the modulation of the inflammatory mechanism in endothelial dysfunction, we quantified the various pro-inflammatory cytokines and endothelial dysfunction-related proteins in the HUVECs with Western blotting and with real-time and quantitative real-time polymerase chain reactions. Results: Co-treatment with PM and AGEs significantly suppressed inflammatory cytokines and adhesion molecule expression. Moreover, the PM treatment for down-regulated inflammatory signals and blocked monocyte adhesion on the HUVECs. Conclusions: Theses results demonstrated that PM, as a potential natural compound, protects AGE-induced endothelial cells against inflammatory cellular dysfunction.

KW - Adhesion molecule

KW - Advanced glycation end-products

KW - Endothelial dysfunction

KW - Monocyte adhesion

KW - Plantamajoside

UR - http://www.scopus.com/inward/record.url?scp=85010021671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010021671&partnerID=8YFLogxK

U2 - 10.1186/s12906-017-1570-1

DO - 10.1186/s12906-017-1570-1

M3 - Article

C2 - 28109289

AN - SCOPUS:85010021671

VL - 17

JO - BMC Complementary and Alternative Medicine

JF - BMC Complementary and Alternative Medicine

SN - 1472-6882

IS - 1

M1 - 66

ER -